BDBM150201 US8980905, 109::US9637499, Compound 109

SMILES FC(F)Oc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c2OC3(CCS(=O)(=O)CC3)Oc12

InChI Key InChIKey=VXTGXSDITDITKB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 150201   

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150201(US8980905, 109 | US9637499, Compound 109)
Affinity DataIC50:  13nMAssay Description:Human recombinant PDE4 (Genbank accession no NM_006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM150201(US8980905, 109 | US9637499, Compound 109)
Affinity DataIC50:  13nMAssay Description:Human recombinant PDE4 (Genbank accession no NM006203) was incubated for 1 hour, with the test compound at concentrations up to 10 μM, with cAMP...More data for this Ligand-Target Pair
In DepthDetails US Patent